Abselion raises 6.6 million to transform protein quantification
BGF - 05-Dec-2024Investors back Amperia for faster, more accessible protein measurement
Join the club for FREE to access the whole archive and other member benefits.
Strategic corporate venture capital in Biotech & Tech
M Ventures is the strategic corporate venture capital arm of Merck KGaA, Darmstadt, Germany, investing globally in transformative ideas across healthcare drug development, life science tools, electronics, and frontier technology & sustainability. With a fund allocation of €600 million, M Ventures actively collaborates with entrepreneurs and co-investors to translate scientific discoveries into commercial success.
Visit website: https://www.m-ventures.com/
Details last updated 12-Feb-2025
Investors back Amperia for faster, more accessible protein measurement